Evidence map›Paper›PMID 14685824›Full record

ArticleJournal of human genetics2004

Association between polymorphism of the dopamine transporter gene and early smoking onset: an interaction risk on nicotine dependence.

Daijun Ling, Tianhua Niu, Yan Feng, Houxun Xing, Xiping Xu

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Journal of human genetics, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 54 citations in OpenAlex.

  1. Pooled it
  2. Dopamine genes and nicotine dependence in treatment-seeking and community smokers.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2009
    Trial
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Advances in genetic studies of substance abuse in China.Shanghai archives of psychiatry · 2013
    Review
  13. Article
  14. Review
  15. Common and unique biological pathways associated with smoking initiation/progression, nicotine dependence, and smoking cessation.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2010
    Article
  16. Variants in nicotinic acetylcholine receptors alpha5 and alpha3 increase risks to nicotine dependence.American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics · 2009
    Article
  17. Article
  18. Article
  19. Overview of the pharmacogenomics of cigarette smoking.The pharmacogenomics journal · 2007
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Daijun LingSchool of Life Science, University of Science and Technology of China, Hefei, Anhui 230027, China.
Tianhua NiuProgram for Population Genetics, Harvard School of Public Health, Harvard University, Boston, MA, USA.
Yan FengProgram for Population Genetics, Harvard School of Public Health, Harvard University, Boston, MA, USA.
Houxun XingProgram for Population Genetics, Harvard School of Public Health, Harvard University, Boston, MA, USA.
Xiping XuSchool of Life Science, University of Science and Technology of China, Hefei, Anhui 230027, China. xu@hsph.harvard.edu.
Harvard University Press · USUniversity of Science and Technology of China · CNHarvard University · US

Funding

GENETICS OF NICOTINE ADDICTION VULNERABILITYR01DA012905 · NIDA · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI XU, XIPING X · 1999 to 2000
$631k
NIDA NIH HHS 1R01-DA-12905
6 · The paper itself

Abstract

Previous studies suggested that a polymorphism in the dopamine transporter gene (SLC6A3) is associated with nicotine dependence and age of smoking onset, but the conclusion was controversial. To detect the association of a G-->A polymorphism (NCBI dbSNP cluster ID: rs27072) in 3'-untranslated region of the SLC6A3 with nicotine dependence and early smoking onset, we recruited 253 sibships including 668 nicotine-dependent siblings from a rural district of China. The sibship disequilibrium tests (SDT) showed that the rs27072-A allele is significantly associated with smoking onset < or =18 years (kappa2=9.78, p=0.003 in severely nicotine-dependent smokers, and kappa2=4.24, p=0.058 in total smokers), but not significantly associated with severe nicotine dependence. Conditional logistic regression showed that the risk of early smoking onset by the rs27072-A allele was almost three times greater in severely nicotine-dependent smokers [Odds ratio (OR)=11.3, 95% confidence interval (CI)=1.5-85.6] than that in total smokers. Linear regression showed that rs27072-A allele also increased the risk of nicotine dependence by early smoking onset compared with homozygous rs27072-G genotype. Although these findings are preliminary and need validation, the results suggest that a polymorphism in the SLC6A3 may play important roles in smoking onset, and there may be an interactive effect between the SLC6A3 and early smoking onset on modulating the susceptibility of nicotine dependence.

Indexed as

Membrane GlycoproteinsNerve Tissue ProteinsAge of OnsetAllelesChinaDNA PrimersDopamine Plasma Membrane Transport ProteinsGenetic Predisposition to DiseaseHumansLinear ModelsLogistic ModelsMembrane Transport ProteinsPolymorphism, Restriction Fragment LengthPolymorphism, Single NucleotideSmokingTobacco Use DisorderDNA PrimersDopamine Plasma Membrane Transport ProteinsMembrane GlycoproteinsMembrane Transport ProteinsNerve Tissue ProteinsSLC6A3 protein, human

Identifiers

PMID14685824
OpenAlexW2004901663

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.